Jammu, March 26:
In a major leap for oncology services in the Union Territory, the All India Institute of Medical Sciences (AIIMS) Jammu has successfully performed the first-ever bilateral breast interstitial brachytherapy. This high-precision procedure marks a historic first not only for the institute but for the entire region of Jammu & Kashmir.
The breakthrough treatment was administered to a female patient diagnosed with synchronous bilateral breast cancer (cancer in both breasts). Having already undergone breast-conserving surgery (BCS) and adjuvant chemotherapy, the patient required a precise radiation “boost” to the tumor beds while preserving healthy tissue and cosmetic appearance.
The Science of Precision: Interstitial Brachytherapy
Interstitial brachytherapy is a sophisticated form of radiation therapy where radioactive sources are placed directly into the target tissue using specialized needles or catheters.
Why this matters for the patient:
-
Conformal Accuracy: Delivers high doses of radiation directly to the tumor site.
-
Organ Preservation: Minimizes radiation exposure to the lungs and heart.
-
Enhanced Recovery: Offers superior cosmetic outcomes compared to traditional external radiation alone.
-
Reduced Toxicity: Lower risk of skin irritation and long-term side effects.
A Multidisciplinary Triumph
The complex procedure was executed under the expert guidance of Dr. D. N. Sharma, Executive Director and CEO of AIIMS Jammu, a renowned pioneer in the field of brachytherapy.
The core clinical team included:
-
Department of Radiation Oncology: Prof. (Dr.) Shabab Lalit Angurana (HOD) and Dr. Girija Priya Sharma (Assistant Professor).
-
Department of Anaesthesiology: Led by Dr. Raksha Kundal (Associate Professor).
-
Medical Physics Team: Mr. Shivam and Ms. Monika, who ensured meticulous dose planning and safety.
Strengthening Local Healthcare
For years, patients in Jammu & Kashmir requiring such advanced oncological interventions often had to travel to Delhi or Chandigarh. The successful implementation of this technically demanding modality at AIIMS Jammu signifies a shift toward accessible, high-precision cancer care within the UT.
“This achievement reflects our commitment to bringing cutting-edge technology to the doorsteps of the people of J&K. By providing such sophisticated treatment locally, we are reducing the emotional and financial burden of travel on our patients,” the institute stated.
With the Department of Radiation Oncology steadily expanding its capabilities, AIIMS Jammu is cementing its position as a premier hub for organ-preserving cancer treatments and innovative medical care in North India.
